Northern Trust’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
403,149
+293,853
| +269% | +$1.18M | ﹤0.01% | 3114 |
|
|
2025
Q1 | $348K | Buy |
109,296
+3,283
| +3% | +$10.4K | ﹤0.01% | 3722 |
|
|
2024
Q4 | $567K | Buy |
106,013
+563
| +0.5% | +$3.01K | ﹤0.01% | 3613 |
|
|
2024
Q3 | $557K | Buy |
105,450
+22,460
| +27% | +$119K | ﹤0.01% | 3551 |
|
|
2024
Q2 | $151K | Buy |
82,990
+18,041
| +28% | +$32.8K | ﹤0.01% | 3946 |
|
|
2024
Q1 | $116K | Sell |
64,949
-68
| -0.1% | -$121 | ﹤0.01% | 4039 |
|
|
2023
Q4 | $114K | Hold |
65,017
| – | – | ﹤0.01% | 4081 |
|
|
2023
Q3 | $94.9K | Hold |
65,017
| – | – | ﹤0.01% | 4026 |
|
|
2023
Q2 | $149K | Buy |
65,017
+3,349
| +5% | +$7.67K | ﹤0.01% | 3927 |
|
|
2023
Q1 | $56.1K | Hold |
61,668
| – | – | ﹤0.01% | 4237 |
|
|
2022
Q4 | $52.4K | Buy |
61,668
+9,442
| +18% | +$8.03K | ﹤0.01% | 4275 |
|
|
2022
Q3 | $43K | Hold |
52,226
| – | – | ﹤0.01% | 4363 |
|
|
2022
Q2 | $52K | Hold |
52,226
| – | – | ﹤0.01% | 4399 |
|
|
2022
Q1 | $86K | Hold |
52,226
| – | – | ﹤0.01% | 4391 |
|
|
2021
Q4 | $126K | Sell |
52,226
-7,036
| -12% | -$17K | ﹤0.01% | 4353 |
|
|
2021
Q3 | $287K | Hold |
59,262
| – | – | ﹤0.01% | 4009 |
|
|
2021
Q2 | $158K | Buy |
59,262
+21,384
| +56% | +$57K | ﹤0.01% | 4235 |
|
|
2021
Q1 | $116K | Buy |
37,878
+8,433
| +29% | +$25.8K | ﹤0.01% | 4253 |
|
|
2020
Q4 | $105K | Hold |
29,445
| – | – | ﹤0.01% | 4103 |
|
|
2020
Q3 | $118K | Buy |
29,445
+2,535
| +9% | +$10.2K | ﹤0.01% | 3931 |
|
|
2020
Q2 | $73K | Hold |
26,910
| – | – | ﹤0.01% | 3981 |
|
|
2020
Q1 | $57K | Hold |
26,910
| – | – | ﹤0.01% | 3932 |
|
|
2019
Q4 | $146K | Sell |
26,910
-336
| -1% | -$1.82K | ﹤0.01% | 3865 |
|
|
2019
Q3 | $82K | Sell |
27,246
-114,471
| -81% | -$345K | ﹤0.01% | 3957 |
|
|
2019
Q2 | $530K | Sell |
141,717
-9,071
| -6% | -$33.9K | ﹤0.01% | 3540 |
|
|
2019
Q1 | $606K | Sell |
150,788
-554
| -0.4% | -$2.23K | ﹤0.01% | 3495 |
|
|
2018
Q4 | $555K | Sell |
151,342
-200
| -0.1% | -$733 | ﹤0.01% | 3531 |
|
|
2018
Q3 | $1.3M | Buy |
151,542
+1,696
| +1% | +$14.5K | ﹤0.01% | 3393 |
|
|
2018
Q2 | $1.65M | Buy |
149,846
+61,276
| +69% | +$673K | ﹤0.01% | 3296 |
|
|
2018
Q1 | $1.02M | Buy |
88,570
+944
| +1% | +$10.9K | ﹤0.01% | 3369 |
|
|
2017
Q4 | $908K | Sell |
87,626
-1,823
| -2% | -$18.9K | ﹤0.01% | 3425 |
|
|
2017
Q3 | $1.43M | Buy |
89,449
+2,924
| +3% | +$46.6K | ﹤0.01% | 3346 |
|
|
2017
Q2 | $1.05M | Buy |
86,525
+42,739
| +98% | +$517K | ﹤0.01% | 3431 |
|
|
2017
Q1 | $910K | Buy |
43,786
+5,792
| +15% | +$120K | ﹤0.01% | 3375 |
|
|
2016
Q4 | $543K | Buy |
37,994
+3,027
| +9% | +$43.3K | ﹤0.01% | 3506 |
|
|
2016
Q3 | $575K | Buy |
34,967
+3,440
| +11% | +$56.6K | ﹤0.01% | 3474 |
|
|
2016
Q2 | $450K | Buy |
+31,527
| New | +$450K | ﹤0.01% | 3539 |
|